Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women
J Paovonen, P Naud, J Salmeron, CM Wheeler, S-N Chow, D Apter, H Kitchener, X Castellsague, JC Teixeira, SR Skinner, J Hedrick, U Jaisamrarn, G Limson, S Garland, A Szarewski, B Romanowski, FY Aoki, TF Schwarz, WAJ Poppe, FX Bosch Show all
The Lancet | ELSEVIER SCIENCE INC | Published : 2009
Awarded by GlaxoSmithKline Biologicals
This study (NCT00122681/580299/008) was funded by GlaxoSmithKline Biologicals. We thank study participants and their families. We wish to dedicate this report to Minnamaija Kekki, a subinvestigator for this study, who sadly passed away.